Department of Gastroenterology Surgery, The Dalian Municipal Central Hospital Affiliated of Dalian Medical University, No. 826 Southwest Road Shahekou District, Dalian, 116033, P.R. China.
Dalian Medical University, Dalian, 116011, P.R. China.
World J Surg Oncol. 2021 Jan 19;19(1):17. doi: 10.1186/s12957-021-02126-4.
The aim of this study was to investigate the overall survival (OS) between proximal gastric cancer (PG) and distal gastric cancer (DG) patients after gastrectomy.
Articles on the prognostic study of PG and DG patients after gastrectomy were collected from the PubMed, EMBASE, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases from the date of establishment until December 2020. The data were statistically analyzed by Stata software (version 11.0, StataCorp).
A total of 10 articles met the inclusion criteria. Meta-analysis showed that the 1-, 3- and 5-year OS rates of PG patients were significantly lower than those of DG patients (RR = 0.898, 95% CI: 0.825 to 0.977, P = 0.013; RR = 0.802, 95% CI: 0.708 to 0.909, P = 0.001; RR = 0.736, 95% CI: 0.642 to 0.844, P = 0.000). After subgroup analysis according to different countries, the combined RR values of were as follows: 1-year OS: eastern countries: RR = 0.966, 95% CI: 0.944 to 0.988, P = 0.003, western countries: RR = 0.687, 95% CI: 0.622 to 0.759, P = 0.000; 3-year OS: eastern countries: RR = 0.846, 95% CI: 0.771 to 0.929, P = 0.000, western countries: RR = 0.742, 95% CI: 0.399 to 1.382, P = 0.348; and 5-year OS: eastern countries: RR = 0.798, 95% CI: 0.716 to 0.889, P = 0.000, western countries: RR = 0.646, 95% CI: 0.414 to 1.008, P = 0.054.
In terms of 1-, 3-, and 5-year OS, PG patients had lower rates than DG patients and the eastern countries/western countries subgroup, but there were no significant differences in 3- and 5-year OS for the western countries. These results merit further clinical validation in future studies. (Registration ID: UMIN000040393; Date of registration: 2020/05/13).
本研究旨在探讨胃切除术后近端胃癌(PG)和远端胃癌(DG)患者的总生存率(OS)。
从 PubMed、EMBASE、Web of Science、Cochrane 图书馆、中国知网(CNKI)、万方和 VIP 数据库中收集了关于 PG 和 DG 患者胃切除术后预后研究的文章,检索时间为建库至 2020 年 12 月。使用 Stata 软件(版本 11.0,StataCorp)对数据进行统计分析。
共纳入 10 篇符合条件的文章。Meta 分析显示,PG 患者的 1、3 和 5 年 OS 率明显低于 DG 患者(RR=0.898,95%CI:0.825 至 0.977,P=0.013;RR=0.802,95%CI:0.708 至 0.909,P=0.001;RR=0.736,95%CI:0.642 至 0.844,P=0.000)。根据不同国家进行亚组分析后,合并 RR 值如下:1 年 OS:东部国家:RR=0.966,95%CI:0.944 至 0.988,P=0.003,西方国家:RR=0.687,95%CI:0.622 至 0.759,P=0.000;3 年 OS:东部国家:RR=0.846,95%CI:0.771 至 0.929,P=0.000,西方国家:RR=0.742,95%CI:0.399 至 1.382,P=0.348;5 年 OS:东部国家:RR=0.798,95%CI:0.716 至 0.889,P=0.000,西方国家:RR=0.646,95%CI:0.414 至 1.008,P=0.054。
在 1、3 和 5 年 OS 方面,PG 患者的生存率低于 DG 患者和东部/西部国家亚组,但西方国家的 3 年和 5 年 OS 无显著差异。这些结果值得在未来的研究中进一步临床验证。(注册号:UMIN000040393;注册日期:2020/05/13)